Susquehanna International Group’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-26,500
| Closed | -$444K | – | 13089 |
|
|
2025
Q3 | $444K | Buy |
+26,500
| New | +$397K | ﹤0.01% | 9232 |
|
|
2023
Q4 | – | Sell |
-10,200
| Closed | -$130K | – | 12913 |
|
|
2023
Q3 | $130K | Buy |
+10,200
| New | +$140K | ﹤0.01% | 10707 |
|
|
2023
Q2 | – | Sell |
-54,500
| Closed | -$813K | – | 12712 |
|
|
2023
Q1 | $813K | Buy |
54,500
+38,100
| +232% | +$577K | ﹤0.01% | 7368 |
|
|
2022
Q4 | $244K | Sell |
16,400
-25,700
| -61% | -$419K | ﹤0.01% | 9623 |
|
|
2022
Q3 | $695K | Sell |
42,100
-87,500
| -68% | -$1.76M | ﹤0.01% | 7586 |
|
|
2022
Q2 | $2.72M | Buy |
129,600
+110,800
| +589% | +$2.26M | ﹤0.01% | 4249 |
|
|
2022
Q1 | $441K | Buy |
18,800
+6,900
| +58% | +$169K | ﹤0.01% | 9293 |
|
|
2021
Q4 | $324K | Sell |
11,900
-29,400
| -71% | -$787K | ﹤0.01% | 10293 |
|
|
2021
Q3 | $1.17M | Sell |
41,300
-5,700
| -12% | -$174K | ﹤0.01% | 7144 |
|
|
2021
Q2 | $1.42M | Sell |
47,000
-1,300
| -3% | -$38.4K | ﹤0.01% | 6815 |
|
|
2021
Q1 | $1.23M | Sell |
48,300
-11,800
| -20% | -$302K | ﹤0.01% | 7176 |
|
|
2020
Q4 | $1.48M | Sell |
60,100
-56,900
| -49% | -$1.07M | ﹤0.01% | 5778 |
|
|
2020
Q3 | $1.91M | Buy |
117,000
+70,600
| +152% | +$1.31M | ﹤0.01% | 4717 |
|
|
2020
Q2 | $793K | Buy |
46,400
+7,700
| +20% | +$114K | ﹤0.01% | 6412 |
|
|
2020
Q1 | $450K | Sell |
38,700
-22,900
| -37% | -$472K | ﹤0.01% | 7154 |
|
|
2019
Q4 | $1.71M | Sell |
61,600
-23,800
| -28% | -$597K | ﹤0.01% | 4583 |
|
|
2019
Q3 | $1.93M | Buy |
85,400
+46,400
| +119% | +$1.06M | ﹤0.01% | 4270 |
|
|
2019
Q2 | $984K | Buy |
39,000
+9,700
| +33% | +$261K | ﹤0.01% | 5693 |
|
|
2019
Q1 | $796K | Buy |
29,300
+12,500
| +74% | +$419K | ﹤0.01% | 5442 |
|
|
2018
Q4 | $554K | Sell |
16,800
-33,500
| -67% | -$1.35M | ﹤0.01% | 5823 |
|
|
2018
Q3 | $2.35M | Sell |
50,300
-4,200
| -8% | -$193K | ﹤0.01% | 3741 |
|
|
2018
Q2 | $2.36M | Buy |
54,500
+12,300
| +29% | +$589K | ﹤0.01% | 3743 |
|
|
2018
Q1 | $2.35M | Buy |
42,200
+12,700
| +43% | +$696K | ﹤0.01% | 3622 |
|
|
2017
Q4 | $1.58M | Sell |
29,500
-12,100
| -29% | -$571K | ﹤0.01% | 4357 |
|
|
2017
Q3 | $1.79M | Buy |
41,600
+1,000
| +2% | +$47.5K | ﹤0.01% | 4112 |
|
|
2017
Q2 | $2.45M | Buy |
40,600
+24,000
| +145% | +$1.42M | ﹤0.01% | 3522 |
|
|
2017
Q1 | $1.15M | Sell |
16,600
-24,300
| -59% | -$1.69M | ﹤0.01% | 4831 |
|
|
2016
Q4 | $2.73M | Buy |
40,900
+6,100
| +18% | +$397K | ﹤0.01% | 3430 |
|
|
2016
Q3 | $2.31M | Buy |
34,800
+8,000
| +30% | +$547K | ﹤0.01% | 3320 |
|
|
2016
Q2 | $1.94M | Sell |
26,800
-14,900
| -36% | -$1.02M | ﹤0.01% | 3625 |
|
|
2016
Q1 | $2.69M | Buy |
41,700
+800
| +2% | +$53.1K | ﹤0.01% | 3224 |
|
|
2015
Q4 | $2.93M | Buy |
40,900
+34,900
| +582% | +$2.58M | ﹤0.01% | 3325 |
|
|
2015
Q3 | $461K | Sell |
6,000
-2,500
| -29% | -$202K | ﹤0.01% | 7276 |
|
|
2015
Q2 | $630K | Buy |
8,500
+1,200
| +16% | +$86.4K | ﹤0.01% | 7169 |
|
|
2015
Q1 | $529K | Sell |
7,300
-43,000
| -85% | -$2.99M | ﹤0.01% | 6991 |
|
|
2014
Q4 | $3.33M | Sell |
50,300
-10,600
| -17% | -$647K | ﹤0.01% | 3555 |
|
|
2014
Q3 | $3.34M | Buy |
60,900
+11,100
| +22% | +$630K | ﹤0.01% | 3706 |
|
|
2014
Q2 | $2.9M | Buy |
49,800
+35,600
| +251% | +$2.09M | ﹤0.01% | 3980 |
|
|
2014
Q1 | $880K | Sell |
14,200
-31,300
| -69% | -$1.82M | ﹤0.01% | 5738 |
|
|
2013
Q4 | $2.43M | Sell |
45,500
-8,100
| -15% | -$435K | ﹤0.01% | 3957 |
|
|
2013
Q3 | $2.69M | Sell |
53,600
-107,400
| -67% | -$5.24M | ﹤0.01% | 3644 |
|
|
2013
Q2 | $7.37M | Buy |
+161,000
| New | +$7.21M | ﹤0.01% | 2156 |
|
Other funds holding MD
VPM
VCM
WA
Susquehanna International Group's MD Position: Q1 2026 in Review
Susquehanna International Group increased its Pediatrix Medical (MD) stake by 35% in Q1 2026, buying an estimated $302K and bringing the position to 56,210 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #7410.
Susquehanna International Group first reported a position in MD in Q2 2013 and has held it in 40 quarters since. The position peaked at $3.89M in Q3 2015. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- Susquehanna International Group held 56,210 shares of Pediatrix Medical worth $1.2M as of Q1 2026.
- Susquehanna International Group bought 14,515 Pediatrix Medical shares in Q1 2026, an estimated $302K.
- Pediatrix Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7410 holding.
- Susquehanna International Group first reported a position in Pediatrix Medical in Q2 2013 and has held it in 40 quarters since.
- Susquehanna International Group's Pediatrix Medical position peaked at $3.89M in Q3 2015.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.